mHealth Solutions Can Significantly
Improve Medication Adherence, Health Outcomes and Patient Quality of Life
(19 November 2012) – Exco InTouch, the leading provider of patient engagement,
data collection and communication solutions for the pharmaceutical and
healthcare sectors, today announced that it will be hosting an informative
webinar with leading global pharmaceutical company, AstraZeneca. The exclusive
webinar will explain how mobile health (mHealth) provides the industry with the
opportunity to engage in multi-layered, personalised solutions that can support
patients in the real world, improve health outcomes and overall quality of
life. Entitled “Going beyond the pill: how mHealth enables Intelligent
Pharmaceuticals”, the webinar will take place on Wednesday 28th
November at 11am EST. Audiences are invited to register in advance at http://bit.ly/XEXKhZ
Presented
by Mark Brincat, Director of Product Strategy and Management at Exco InTouch
and Matthew Bonam, Pharmaceutical Project Director at AstraZeneca, the webinar
will introduce the importance of mHealth in the pharmaceutical industry,
explaining its ability to offer pharmaceutical companies adaptive, multi-modal
solutions which can provide a better understanding of the patient experience,
and as a result, provide altered patient behavior and improved medication
adherence. It will draw upon the positive experiences had by AstraZeneca in
improving health outcomes through mHealth programs, as well as discussing AstraZeneca’s
vision for ‘Intelligent Pharmaceuticals’, with particular emphasis on the
necessity of growing health solutions ‘beyond the pill’.
Mark
Brincat explains, “The webinar will educate and inform audiences on the
importance and benefits of mHealth in the future of the pharmaceutical industry,
with exclusive insight from AstraZeneca on its vision for a future of
‘Intelligent Pharmaceuticals’. We want audiences to understand how adaptive
solutions can be designed exclusively for condition specific areas, with a
focus on delivering the correct patient behaviour changes. As the
pharmaceutical industry faces challenging times, with stiff competition, mounting
price pressure and continually increasing costs, it has never been more critical
to engage with patients. We believe that mHealth has an important part to play
in providing sponsors and healthcare providers with a mechanism to effectively engage
with patients through a multi-layered, personalised approach.”
For
more information please join the webinar on Wednesday 28th November
at 11am EST.
-ENDS-
For further press information please
contact: Michelle Valentine, The Scott Partnership, 1 Whiteside, Station Road,
Holmes Chapel, Cheshire CW4 8AA Tel: +44 1477 539539 Fax: +44 1477 539540
e-mail: exco@scottpr.com
Exco
InTouch is the trusted global innovator of regulatory compliant, mobile patient
engagement solutions for life sciences and healthcare companies involved in
clinical, late phase and mHealth research. Using a combination of
patented software and services delivered in a cloud environment, Exco’s solutions
can be utilised on any electronic device. This safe, secure platform
facilitates compliant patient communication across the clinical development
process from early phase development right through to long term studies and
mHealth. As a result, Exco can help its customers to improve clinical outcomes
by putting the patient at the heart of a study and enhancing the overall
patient experience.
Exco’s
solutions are currently being used by hundreds of thousands of patients in over
seventy countries, delivered in the local language and are fully compliant with
HIPAA regulations, FDA CFR 21 Part 11 and all electronic communication privacy
directives.
No comments:
Post a Comment